TreVia has improved accessibility of retinal screenings, offering them in convenient locations such as primary care offices. Thanks to TreVia’s solutions, I am able to provide preventative care as a retinal specialist, identifying and treating diseases in early stages before patients lose vision.
Why TreVia…
What we believe
- Our efforts will improve the quality of life for diabetes patients
- We will have a meaningful impact on society—in the US and around the world
- It’s critical to reinvent how diabetes care is being accessed and delivered
- High standards should never be compromised
- TreVia is the best trusted partner
What we do
TreVia is a health care company that provides technology-enabled services, including digital diabetic retinopathy screenings, for the prevention of diabetic complications...
Who we benefit
...to empower physicians, health organizations, payers, retailers and patients with solutions and tools so they can take a more active, collaborative role in diabetes care...
Value we bring
...and measurably impact diabetes outcomes, the patient experience and the cost of treating diabetes.
To learn more about the value of what we do and the impact we’re making in diabetes care today, click HERE.
Invest in what you can measure...
We’re Having a Meaningful Impact in Preventing Blindness
Since inception, TreVia has helped over 185,000 diabetic patients through our digital diabetic retinopathy screenings. This number will continue to grow as our solution is implemented across the globe.
We’re Detecting a Multitude of Eye Issues That Have Gone Undetected
In addition to diabetic retinopathy, TreVia has identified other eye health issues that otherwise would have gone undetected. These include macular degeneration, macular edema.
We’re Identifying Eye Health Issues That Require Medical Attention
TreVia is identifying eye health issues that may have worsened without additional medical attention. Sometimes, the issue just needs closer monitoring. In more severe cases, a cost-effective procedure such as laser photocoagulation or intravitreal injection can treat the issue early to prevent vision loss and possible expensive vitrectomy surgery.
